Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (3y) (2013 - 2025)
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | -39.19% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -177.73% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 46.78% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 66.14% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -44.69% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -246.81% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -72.08% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Ironwood Pharmaceuticals | 669.13 Mn | 590.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -66.67% |
| Sep 30, 2025 | 68.82% |
| Jun 30, 2025 | 71.67% |
| Mar 31, 2025 | -51.02% |
| Dec 31, 2023 | -430.82% |
| Jun 30, 2023 | -1,285.26% |
| Mar 31, 2023 | 79.17% |
| Dec 31, 2022 | 26.20% |
| Sep 30, 2022 | 72.22% |
| Jun 30, 2022 | 66.91% |
| Mar 31, 2022 | 85.54% |
| Dec 31, 2021 | -26.12% |
| Dec 31, 2020 | 90.48% |
| Jun 30, 2020 | -26.10% |
| Mar 31, 2020 | -26.33% |
| Dec 31, 2019 | 71.54% |
| Sep 30, 2019 | 67.59% |
| Jun 30, 2019 | -35.90% |
| Mar 31, 2019 | -28.61% |
| Sep 30, 2018 | 33.94% |